Ainos Inc. has exclusive patent rights in new Abkommen from Investing.com

Ainos, Inc., a pharmaceutical company with Sitz in San Diego, California, has established an Erweiterung Seiner Partnership with the Taiwan Carbon Nano Technology Corporation (TCNT) during a new venture. If you enable the third world, you can have the night guided by your best products, so that you get the same unity and exclusive rights for a Stickstoff-Sauerstoff-Trennmaschine for a medical anwendungen-umfasst.

If the night is changed by the American company, Ainos will reimburse the exclusive Nutzung best patents – one of the following is non-exclusive clause. You will receive TCNT from 16.10.2024 for a one-year monthly payment of 50,000 US Dollars with a 5% refund for this exclusive offer. After this period, the Unternehmen can erörtern other Zahlungsvereinbarungen and Lizenzierungsmethods.

This venture is part of the successful acquisition of Ainos, its product portfolio in pharmaceutical and medical technology as a whole. The venture with TCNT, which through the direct involvement and prospect of Ainos KY, a company in the Cayman Islands, a multiple betteiligung and an Ainos stop, is a more strategic strategy for TCNT’s technology and patent.

On 17.10.2024 Ainos KY stopped and 62.9% of the Stimmrechte an Ainos, Inc., was a strong current of the Unternehmensentscheidungen bedeutet. It is a fact that the financing of the financing is exclusive for patent settlement in the years when a rolling role for the betrieb and the product of a game is played.

In other cases, Ainos Inc. reports. joined Entwicklungen in his Geschäftsaktivitäten. The Unternehmen department has the insurance obligation for the following activities and the best business operations of KCCW Accountancy Corp. carried out with an unregistered Wirtschaftsprüfungsunternehmen registration. There is a patent in Taiwan for its antiviral drug VELDONA®, which enables its treatment and prevention of coronavirus infections. The AI ​​Nose Technology of the Unternehmens has achieved an efficiency of 79% in the identification of flowing organic compounds in Japanese Halbleiterfabriken, improving security and efficiency in the industrial sector.

A strategically exclusive solution has been found for 10 patents on Taiwan Carbon Nano Technology in a value of US$5.4 million, an AI Nose and Point-of-Care testing technology has been expanded. The U.S. FDA has granted orphan drug designation to Ainos’ interferon drug VELDONA® for the treatment of oral care in HIV-positive patients and a clinical trial will begin at National Taiwan University Hospital.

Allerdings are probably one of the Nasdaq’s most common delisting activities, spreading the trade among the hereditary mind bones that have fallen. The Unternehmen have a Gnadenfrist until 13.01.2025, um the Compliance wiederherzustellen. The development of the business at Ainos Inc. has come to an end.

InvestingPro Insights

The young venture of the partnership of Ainos, Inc. TCNT takes a critical look at the international market, with data from InvestingPro. With a market capitalization of 4.58 Million US Dollars, Ainos operates in a large financial environment. The sum of money for the living quarters of 2023 will yield 0.07 million US dollars empty, with a certain amount of 97.73% over time.

Check out the relevant InvestingPro tips to understand Ainos’ current situation. Ersten’s “verbrennt das Unternehmen schnell Bargeld”, was the Bedeutung of the new Abkommens for potential Umsatzgenerierung hervorhebt. Zweitens “leads to negative gross profit margins”, on the date a negative gross profit margin of -316.61% for the last two weeks of the quarter 2023 said.

The fact that they have been successful in this regard has been taken into account in the last week of a beach rent with a return of 17.32%, which may have been the market top view of the new partnerships in broader mirrors. This last time you can have a strong performance is that the action is performed in a year at a rate of 82.99%.

Please note that the Ainos in Betracht see, some beaches, that InvestingPro 10 sister Tips for this Action-bietet, which a new analysis of the financial prosperity and market position of the Unternehmens ermöglichen.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.